% | $
Quotes you view appear here for quick access.

Genomic Health Inc. Message Board

  • t_rextile_dysfunction t_rextile_dysfunction Apr 4, 2013 12:01 AM Flag

    biopsy-based Oncotype DX® prostate cancer test available by end of 2Q


    Oral Presentation: "Development and validation of the biopsy-based genomic prostate score (GPS) as a predictor of high grade or extracapsular prostate cancer to improve patient selection for active surveillance" (Abstract #2131)

    May 8, 2013, 8:00-10:00 a.m. Pacific Time

    This topic is deleted.
28.82-0.02(-0.07%)9:45 AMEDT